iRhythm director sold 5,312 shares; options exercised at $10.71 under 10b5-1 plan
Rhea-AI Filing Summary
iRhythm Technologies director Abhijit Talwalkar executed a Rule 10b5-1 trading plan on August 11, 2025. He exercised employee stock options to acquire 5,312 shares at an exercise price of $10.71 and then sold those shares in two series: 3,183 shares at a weighted-average price of $157.5723 and 2,129 shares at a weighted-average price of $158.6792. The reported sale price ranges were $157.2350–$158.1800 and $158.3100–$159.0000. Following these transactions, his beneficial ownership is reported as 20,299 shares. The option exercised was originally granted May 23, 2016 and expires May 23, 2026.
Positive
- Transactions were executed pursuant to a Rule 10b5-1 trading plan established May 12, 2025
- Option exercise details provided: 5,312 shares exercised at a $10.71 strike
- Filing discloses weighted-average sale prices and exact sale price ranges
Negative
- Director sold a total of 5,312 shares on August 11, 2025 (3,183 and 2,129 shares)
- Reported beneficial ownership declined to 20,299 shares after the transactions
Insights
TL;DR: Director used a pre-established 10b5-1 plan to exercise options and sell shares, leaving 20,299 shares outstanding.
The filings show a contemporaneous exercise of 5,312 option shares at a $10.71 strike and subsequent sales executed the same day under a Rule 10b5-1 plan established May 12, 2025. Sales were executed in two blocks at weighted-average prices of $157.5723 and $158.6792, with reported price ranges for the transactions. The net effect reduced reported beneficial ownership from the pre-transaction level to 20,299 shares. This disclosure is factual and routine for scheduled insider liquidity events.
TL;DR: Transactions were performed under a documented 10b5-1 plan and include option exercise details and expiration information.
The Form 4 confirms the transactions were effected pursuant to a Rule 10b5-1 trading plan established May 12, 2025, and provides option grant and expiration details: the exercised option was granted May 23, 2016 for 21,248 shares, vested monthly, and expires May 23, 2026. The report is signed by an attorney-in-fact and includes weighted-average sale prices and ranges, meeting typical disclosure requirements for insider trades.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 5,312 | $0.00 | -- |
| Exercise | Common Stock | 5,312 | $10.71 | $57K |
| Sale | Common Stock | 3,183 | $157.5723 | $502K |
| Sale | Common Stock | 2,129 | $158.6792 | $338K |
Footnotes (1)
- All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $157.2350 to a high of $158.1800, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 11, 2025. The actual sale prices ranged from a low of $158.3100 to a high of $159.0000, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points. The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.
